Mangiferin was found to bind at active site of Leishmania infantum Try R with lowest binding energy and RMSD values to be -9.16 Kcal/Mol and 1.98 respectively. Docking analysis of Try R with ligand enabled us to identify specific residues viz. Phe-203, Glu-202, Asp-218, Pro-336, Try-221 and Phe-270, within the Try R binding pocket to play an important role in ligand binding affinity. The availability of Try R built model, together with insights gained from docking analysis will promote the rational design of potent and selective Try R inhibitor as antileishmanial therapeutic. The study contributes towards understanding mechanism of antileshmanial effect of the mangiferin. We have surveyed the available literature to summarize the inhibition of Try R activity of this natural compound. Thus on the basis of our in silico studies we hypothesize that this compound into mangiferin can be inhibitory effect on against leishmaniasis.
Introduction
Trypanosomatids cause various lethal forms of tropical human diseases including Leishmaniasis, which is caused by over twenty different species of Leishmania parasite (e.g., L. donovoni, L. infantum, L. major, L. mexicana, etc.) . Leishmaniasis causes several clinical disabilities like disseminated visceral infection (Kala azar). Vector of the disease is female Phlebotomine sandfly, a dipteran, which transmits the parasite to human during blood sucking (Myler and Fasel, 2008) . This disease is endemic in low-income population of Central and South American countries (Tempone et al., 2005) . Commonly available drugs for Leishmaniasis have severe side effects, high cost and low efficacy (Shukla et al., 2010) .
Trypanothione reductase (E.C.1.6.4.8) is a member of the disulfide oxidoreductase family of enzymes (Fairlamb and Cerami, 1992 ) that presents an attractive target for the development of the new drugs by rational inhibitor design. Tyr R is an NADPH-dependent flavoprotein unique to protozoan parasites from the genera Trypanosoma and Leishmania. Try R has long constituted an attractive target for chemotherapeutic research in relation to leishmaniasis and other trypanosomatid caused diseases since there are numerous evidences indicating that the enzyme is essential for parasite survival as well as specific in leishmania has not been found in human (Dumas et al., 1997; Tovar et al., 1998) .
Mangiferin bioactivities have been related with radical scavenging (Miliauskas et al., 2004) as well as inhibition of oxidative stress (Murunganandan et al., 2005) and complex formation with Fe(III) where knowledge regarding its fundamental chemical behavior could be helpful for a better understanding of its biological pathways. However, there is little information related to quantum mechanics for this molecule (Zhang, 1999) and almost none about docking studies, essential to understand its mechanisms of biological action.
Mangiferin is a plant product of mangifera indica which has been reported to have multiple pharmacological potentials like antioxidant activity, immunomodulatory effect, anti inflammatory effect, effect of improving dyslipidemia, therapeutic effect on periodontal disease and antidiabetic effect on both type 1 as well as type 2 diabetes (Dar et al., 2005; Guha et al., 1996; Bhowmik et al., 2009; Niu et al., 2012; Duang et al., 2011) .
The detailed in silico analyses of probable inhibition as well as interaction of the models were performed with high binding affinity. However there is no conclusive report as to whether the antileishmanial activity of the mangiferin. In the present study, the structural models of the mangiferin in the trypanothione reductase binding sites has been carried out, which may facilitate further development of more potent antileishmanial agents. Mangiferin might be a promising additive in combined drug inhibitor of trypanothione reductase. Protein-lingand docking was performed between the molecular models of L. infantum Try R and Mangiferin. The studies presented in this medical hypothesis will be useful to design molecules that may have antileishmanial activity.
Materials and Methods
Python 2.7 -language was downloaded from www.python.com, Cygwin c:\program and Python 2.5 were simultaneously downloaded from www.cygwin.com, Molecular graphics laboratory (MGL) tools and AutoDock4.2 was downloaded from www.scripps.edu, Discovery studio visualizer 2.5.5 was downloaded from www.accelerys.com.
The docking of Mangiferin into the binding site of the Try R protein was explored using Autodock software, which has been shown to be powerful tools for molecular recognition. To validate the molecular modeling programs, we first evaluated the docking accuracies of Autodock by docking with known Try R inhibitor, mangiferin into the binding site.
Protein preparation for docking: The 3D structure of Leishmania Infantum Try R (PDB ID: 2jk6) was downloaded from Protein Data Bank (PDB) (http: // www.pdb.org/pdb/home/home.do), before initiating the docking simulations, all non-protein molecules were removed from Try R (Figure 1) ; for any alternative atom locations only the first location was retained. All the docking calculations were performed by using Autodock 4.0. Try R was modified by adding polar hydrogen's and then kept rigid in the docking process, whereas all the torsional bonds of ligands were set free by Ligand module in Autodock Tools. Various inhibitors provide an excellent basic for using structurebased approaches for the discovery of new inhibitors.
Ligand preparation for docking:
The flavonoid ligand like Mangiferin was built using Chemsketch and optimized using "Prepare Ligands" in the AutoDock 4.2 for docking studies. The optimized ligand molecules were docked into refined Trypanothione reductase model using "LigandFit" in the AutoDock 4.2.
Binding sites of these complexes were identified as described previously. The conformation of binding site was constructed manually to accommodate with mangiferin. The validation of the docking accuracy was done by docking of the Mangiferin into its binding site of Trypanothione reductase. AutoDock binding affinities of the mangiferin into Trypanothione reductase were evaluated by the binding free energies (kcal/ mol), inhibition constants (Ki), hydrogen bonds, and RMSD values.
Molecular docking: AutoDock 4.2 suite was used as molecular-docking tool in order to carry out the docking simulations. The Auto Dock 4.2 program was used to investigate ligand binding to structurally refined Try R model using a default grid spacing of 0.375 Å and the grid points in X, Y and Z axis were set to 60 × 60 × 60 Å. The search was based on the Lamarckian genetic algorithm (Oprea et al., 2001 ) and the results were analyzed using binding energy. For each ligand, a docking experiment consisting of 100 stimulations was performed and the analysis was based on binding free energies and root mean square deviation (RMSD) values, and the ligand molecules were then ranked in the order of increasing docking energies.
Results and Discussion
The docking of mangiferin into the binding site of the Try-R protein was explored using Autodock software, Figure 1 : The modelled structure of trypanothione reductase receptor which has been shown to be powerful tools for molecular recognition. To validate the molecular modeling programs, we first evaluated the docking accuracies of Autodock by docking with known Try R inhibitor, mangiferin into the binding site. The 3D structure of Leishmania Infantum Try R (PDB ID: 2jk6) was downloaded from Protein Data Bank (PDB) (http: //www.pdb.org/pdb/home/home.do), in these mangiferin as ligand for our in silico studies shown in Figure 2 .
Molecular docking methods are commonly used for predicting binding modes to proteins and energies of ligands (Bikadi and Hazai, 2009) . Docking was accomplished employing Autodock 4.0 which is a suite of automated docking tools was used to predict the affinity, activity, binding orientation of mangiferin to our target protein molecule Try R. Analysis was based on Etotal or free energy of binding, lowest docked energy, and calculated RMSD values. For each approach, the number of hits, the RMSD value of the best hit (with the lowest RMSD) based on shape complementarity are listed in Table I . Mangiferin was found to bind at active site of L. infantum Try R with lowest binding energy and RMSD values to be -9.16 Kcal/Mol and 1.98 respectively ( Table I) Our in silico experiments demonstrate that mangiferin binds Try R, and also is itself inhibits its function and thus may act as a drug.
A detailed literature survey yielded that the inhibitory pathway has to be considered as a potential drug target against the parasitic protozoan species of Trypanosoma and Leishmania infantum Try R using bioinformatics tools. We can hypothesize that mangiferin may be considered to play an important role in inhibiting the Try R activity and progression of leishmaniasis. This mangiferin can be promising candidate for the development towards the design of anti-leishmanial drug as therapeutic compound.
In conclusion, the results of the present study clearly demonstrated the in silico molecular docking studies of mangiferin with Try R enzyme exhibited binding interactions and warrants further studies needed for the development of potent trypanothione reductase inhibitor for the treatment of leishmaniasis. Number of distinct conformational clusters found = 4, out of 50 runs, Using an RMSD -tolerance of 2.0 Å
